Levodopa

Where the papers sit

11 papers from the last 6 months study levodopa directly · updated from PubMed 26 Sept 2026

• Dopamine Biology in Parkinsonism

  Dopamine dysfunction remains the common focus, spanning levodopa combinations, reserpine models, neuroprotective compounds, and rare dopa-responsive disorders. Studies compare blood dopamine with levodopa, carbidopa, entacapone, or benserazide and test motor recovery in experimental parkinsonism. Ferroptosis markers and genetic findings broaden the search for biomarkers and mechanisms. The work is still exploratory, with no single treatment or biomarker emerging as definitive.

  5 papers · 45.5%

• Gait Effects in Parkinson Disease

  Levodopa exposure is being examined alongside freezing of gait and altered walking mechanics in Parkinson disease. Cohort analyses focus on gait severity, disease stage, and the clinical characteristics associated with freezing. Laboratory work links levodopa to shifts in vertical center of mass and muscle synergy structure. The evidence characterizes gait effects rather than establishing a consistent strategy to prevent them.

  2 papers · 18.2%

• Others — Levodopa and Parkinsonism

  Levodopa-related work here ranges from pharmacovigilance and rare metabolic parkinsonism to drug delivery and antidyskinetic compounds. FAERS analysis compares adverse-event signals for levodopa and pramipexole, while glutaric aciduria type 1 illustrates an alternative cause of parkinsonism. Nanoplatform design seeks more targeted levodopa delivery, and animal studies test reduction of levodopa-induced dyskinesia. These directions do not form a unified research program.

  4 papers · 36.4%